NAC Pre-Administration Prevents Cardiac Mitochondrial Bioenergetics, Dynamics, Biogenesis, and Redox Alteration in Folic Acid-AKI-Induced Cardio-Renal Syndrome Type 3

• Egile Nagusiak: Belén Cuevas-López (Egilea), Edgar Ignacio Romero-Ramirez (Egilea), Fernando E. García-Arroyo (Egilea), Edilia Tapia (Egilea), Juan Carlos León-Contreras (Egilea), Alejandro Silva-Palacios (Egilea), Francisco-Javier Roldán (Egilea), Omar Noel Medina Campos (Egilea), Luz Hernandez-Esquivel (Egilea), Alvaro Marín-Hernández (Egilea), José Guillermo Gonzaga-Sánchez (Egilea), Rogelio Hernández-Pando (Egilea), José Pedraza-Chaverri (Egilea), Laura Gabriela Sánchez-Lozada (Egilea), Omar Emiliano Aparicio-Trejo (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2023-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The incidence of kidney disease is increasing worldwide. Acute kidney injury (AKI) can strongly favor cardio-renal syndrome (CRS) type 3 development. However, the mechanism involved in CRS development is not entirely understood. In this sense, mitochondrial impairment in both organs has become a cen...